{
    "clinical_study": {
        "@rank": "159934", 
        "arm_group": [
            {
                "arm_group_label": "Transcatheter closure group", 
                "description": "Migraine patients with patent foreman ovale (PFO)\uff0cwho meet the criteria and agree to conduct closure of patent foramen ovale will be selected to this group."
            }, 
            {
                "arm_group_label": "Contrast group", 
                "description": "Migraine patients with PFO\uff0cwho meet the criteria but don't agree to conduct closure of patent foramen ovale will be selected to this group."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of the study is to evaluate effectiveness and safety of transcatheter patent\n      foramen ovale closure for migraine."
        }, 
        "brief_title": "Effectiveness and Safety of Transcatheter Patent Foramen Ovale Closure for Migraine", 
        "condition": [
            "Foramen Ovale, Patent", 
            "Migraine"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Foramen Ovale, Patent", 
                "Migraine Disorders"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Clinical history of migraine diagnosed by a neurologist according to the\n             International Classification of Headache Disorders\n\n          -  Transcranial Doppler evidence of right-to-left shunt(RLS) and echocardiographic\n             evidence of PFO\uff0cof which the degree is moderate to large RLS\n\n          -  Subjects who have not responded to or cannot take common migraine preventive\n             medications\n\n          -  Willing to participate in follow-up visits\n\n        Additional Inclusion Criteria:\n\n          -  Transcatheter closure group: Closure of PFO is performed\n\n          -  Contrast group: Subjects who meet the Inclusion Criteria, but refuse to undergo\n             closure procedure\n\n        Exclusion Criteria:\n\n          -  Seizure disorder\n\n          -  Other organic central nervous system disease\n\n          -  Subjects whose headaches are other than migraine, such as a result of traumatic head\n             or neck injury\n\n          -  Evidence of alcohol, drug or substance abuse within the previous year\n\n        Additional Exclusion Criteria for Transcatheter closure group:\n\n          -  Subjects with intracardiac thrombus or tumor\n\n          -  Subjects who have an acute or recent (within 6 months) myocardial infarction or\n             unstable angina\n\n          -  Subjects with left ventricular aneurysm or akinesis\n\n          -  Subjects with atrial fibrillation/atrial flutter (chronic or intermittent)\n\n          -  Subjects with another source of right to left shunt identified at baseline, including\n             an atrial septal defect and/or fenestrated septum\n\n          -  Subjects with contraindication to aspirin or Clopidogrel therapy\n\n          -  Pregnant or desire to become pregnant within the next year"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "65 Years", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "We diagnosis PFO through contrast-enhanced transcranial Doppler (c-TCD) and Transthroracic\n        Echocardiography (TTE). The migraine patients who should undergo a patent foreman ovale\n        closure and would like to will be selected to Transcatheter closure group, while those who\n        refuse such procedure will be selected to Contrast group."
            }
        }, 
        "enrollment": {
            "#text": "200", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 29, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02127294", 
            "org_study_id": "PFO-1shsf"
        }, 
        "intervention": {
            "arm_group_label": "Transcatheter closure group", 
            "intervention_name": "transcatheter patent foreman ovale closure", 
            "intervention_type": "Device"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Foramen Ovale, Patent", 
            "migraine", 
            "transcatheter patent foramen ovale closure", 
            "contrast-enhanced transcranial Doppler", 
            "Transthoracic Echocardiography"
        ], 
        "lastchanged_date": "April 29, 2014", 
        "location": {
            "facility": {
                "address": {
                    "city": "Changchun", 
                    "country": "China", 
                    "state": "Jilin", 
                    "zip": "130000"
                }, 
                "name": "First Hospital of Jilin University"
            }
        }, 
        "location_countries": {
            "country": "China"
        }, 
        "number_of_groups": "2", 
        "official_title": "Effectiveness and Safety of Transcatheter Patent Foramen Ovale Closure for Migraine", 
        "other_outcome": {
            "measure": "Headache Impact Test-6", 
            "safety_issue": "No", 
            "time_frame": "within one year period, at least 3 months"
        }, 
        "overall_official": [
            {
                "affiliation": "First Hospital of Jilin University", 
                "last_name": "Yi Yang, MD, PhD", 
                "role": "Study Chair"
            }, 
            {
                "affiliation": "First Hospital of Jilin University", 
                "last_name": "Yingqi Xing, MD, PhD", 
                "role": "Study Director"
            }, 
            {
                "affiliation": "First Hospital of Jilin University", 
                "last_name": "Yuzhu Guo", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Enrolling by invitation", 
        "oversight_info": {
            "authority": "China: Ethics Committee", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "Contrast-enhanced Transcranial Doppler", 
            "safety_issue": "No", 
            "time_frame": "within one year period"
        }, 
        "reference": {
            "PMID": "22747847", 
            "citation": "Yang Y, Guo ZN, Wu J, Jin H, Wang X, Xu J, Feng J, Xing Y. Prevalence and extent of right-to-left shunt in migraine: a survey of 217 Chinese patients. Eur J Neurol. 2012 Oct;19(10):1367-72. doi: 10.1111/j.1468-1331.2012.03793.x. Epub 2012 Jun 30."
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02127294"
        }, 
        "responsible_party": {
            "investigator_affiliation": "First Hospital of Jilin University", 
            "investigator_full_name": "Yi Yang", 
            "investigator_title": "Associated Dean of First Hospital of Jilin University", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": {
            "measure": "Transthoracic Echocardiography", 
            "safety_issue": "Yes", 
            "time_frame": "within one year period"
        }, 
        "source": "First Hospital of Jilin University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Yi Yang", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "January 2013", 
        "study_design": "Observational Model: Cohort, Time Perspective: Prospective", 
        "study_type": "Observational", 
        "verification_date": "April 2014"
    }
}